2023-503987-18-00
Completed
Phase 1
A Trial Investigating the pain-relieving properties of Lu AG06474 in Healthy Adult Participants
Overview
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- H. Lundbeck A/S
- Enrollment
- 24
- Locations
- 1
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Clinical Trial Information
Scientific
H. Lundbeck A/S
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
A study investigating the pain-relieving effects of a new drug in healthy adults2022-501804-80-00Trevena Inc.24
Recruiting
Phase 1
Research into new test methods to measure pain with two existing drugs (nefopam and oxycodone)2025-522389-66-00Centre for Human Drug Research24
Recruiting
Phase 3
Effect of preventive analgesia by injection of a local anesthetic before vaginal incision for hysterectomy by the vNOTES approach: a randomized double-blind study
ANOTES study2023-504926-20-00CHU De Rouen108
Not yet recruiting
Not Applicable
Prospective observational study on pain relief, functional evaluation and safety of human adipose-derived mesenchymal stem cell culture supernatant solution for acute and chronic pain Singl-center, single-arm open studyAcute pain and Chronic painJPRN-UMIN000049726General incorporated association Advalife Science SINCLAIR GINZA CLINIC30
Not yet recruiting
Not Applicable
Clinical evaluation on the pain-reducing effect of Aconinsan for burning mouth syndromeBurning mouth syndromeJPRN-UMIN000044521Saga University64